Form 4: Axogen Director Receives Equity Grant

Axogen, Inc. reports that Director William P. Burke received an annual equity grant of restricted stock units valued at $185,000.

Summary

• William P. Burke, a Director at Axogen, Inc., was granted restricted stock units (RSUs) on June 24, 2026.
• The grant consists of 4,392 RSUs, representing a contingent right to receive one share of Axogen, Inc. common stock per unit.
• This grant is an annual equity award for his service as a Director on the Axogen, Inc. Board of Directors.
• The total valuation of the equity grant was $185,000 as of the grant date.
• These RSUs vest on June 24, 2027, which is the one-year anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard director equity grant without significant financial performance indicators or strategic shifts.

Positives

• Director William P. Burke received a significant equity grant, indicating continued investment in leadership.
• The grant is valued at $185,000, reflecting a substantial award for services rendered.
• The equity grant vests in one year, aligning the director's interests with the company's long-term performance.

Future Outlook

The restricted stock units granted to Director William P. Burke are set to vest on June 24, 2027, aligning his incentives with the company's performance over the next year.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the biotechnology and medical device sectors, such as Axogen, Inc., to attract and retain experienced leadership and align their interests with shareholders.

Stakeholder Impact

• Shareholders: The equity grant aligns director compensation with company performance, potentially benefiting shareholders through motivated leadership.
• Employees: Standard compensation practice for directors, not directly impacting employees.
• Management: Reinforces the company's commitment to retaining experienced board members.

Next Steps

• Director William P. Burke will hold the restricted stock units until their vesting date on June 24, 2027.
• Upon vesting, the restricted stock units will convert into shares of Axogen, Inc. common stock.

Key Dates

Keywords

Axogen Inc, AXGN, Form 4, Director Compensation, Equity Grant, Restricted Stock Units, William P. Burke, SEC Filing